AzTrials
AzTrials

DementiaNCT02840318

Compassion Pilot Intervention Study to Enhanced Integrated Care for People With Severe Memory Problems

A study testing Compassion Intervention in people with Dementia, run by University College, London at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators developed the theory-driven 'Compassion Intervention', an integrated, interdisciplinary approach to address existing gaps in end-of-life care for people with advanced dementia. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Dementia
What is being tested?
Compassion Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited Kingdom
Study dates
Feb 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • residents residing in one of the two participating care homes;
  • memory problems indicating a diagnosis of dementia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV);
  • Functional Assessment Staging scale (FAST) grade 6a (difficulty putting on clothing) and above (unable to hold head up) (Reisberg, 1988);
  • Comorbidities or unmanaged symptoms such as agitation, recurrent infections, pain and pressure ulcers.

Who cannot join

  • Residents who indicate either verbally or non-verbally that they do not wish to participate.
  • Residents who are moribund, in a coma, or those where there are clinical concerns that may preclude them being approached.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University College, London

    London, Select One..., W1T 7NF

Other trials in United Kingdom

About this study

Official title: The Compassion Intervention: A Pilot Study of Enhanced Integrated Care for People With Severe Memory Problems

The investigators developed the theory-driven 'Compassion Intervention', an integrated, interdisciplinary approach to address existing gaps in end-of-life care for people with advanced dementia. The Intervention consists of two core components: facilitation of an integrated, multi-disciplinary approach to assessment, treatment and care; and education, training and support for formal and informal carers. The intervention is implemented by an Interdisciplinary Care Leader. The primary aim is to understand how the Intervention operates in two care homes (with nursing support) in two different health and social care economies; one in the Camden Commissioning Group and one in the Barnet Commissioning Group, both in London, UK. The secondary aim is to collect preliminary outcome data and estimate the cost of employing an Interdisciplinary Care Leader to inform further evaluative studies. The final aim is to check that the Intervention causes no harm to residents and their family carers.

Read the detailed description

Within a three-year research programme the investigators used the RAND/UCLA Appropriateness Method (Fitch, 2001) to achieve national consensus on the components of Compassion ('the Intervention'), a complex intervention for a model of end of life care for people with advanced dementia. The Intervention consists of two core components: facilitation of an integrated, multi-disciplinary approach to assessment, treatment and care; and education, training and support for formal and informal carers. The development is described in detail in a manual and a publication (Jones, 2015). The Intervention is coordinated by an Advanced Dementia Interdisciplinary Care Leader (ICL) The ICL role requires extensive clinical experience in care of frail older people and those with dementia, particularly towards end of life. Skills may be drawn from the fields of nursing, social work or a profession allied to medicine. This theory-driven approach to improving end of life care in advanced dementia has not previously been tested in a real-world setting. The protocol is published (Elliott, 2014).

The study will be an exploratory, naturalistic implementation study of the Compassion Intervention following the principles of dynamic sustainability, recognising that implementing protocols in real-life settings requires adaptations, and that rigid adherence to guidelines tested in controlled settings may not be suitable or effective in broader contexts (Chambers, 2013). The investigators structured their approach using the phases of implementation described by Grol and colleagues (2007) including orientation, insight, acceptance, change and maintenance. A full time ICL with a social care background and considerable experience working with people with dementia in care homes was employed. The ICL will be supervised by clinicians with palliative and dementia expertise within the research team and two external clinicians.

Two care homes, both predominately nursing home level of care, were invited to participate having been involved in an earlier phase of the research programme; a longitudinal (9 months) cohort study to examine the needs of people with advanced dementia and their family carers (Jones, 2012). Care home managers gave written consent for their site to participate, and permission for the ICL to carry out clinical assessments of eligible residents and have access to their files. Managers will identify eligible residents. Implementation will occur over 15 months. In month 1, in each care home, the ICL will meet with care home managers, deputy managers and key external healthcare professionals who visit the care homes. Posters promoting the intervention will be displayed in each care home. The Intervention was launched in Care Home 1 in May 2014 and Care Home 2 in June 2014. The ICL will be actively engaged in each care home for six months to co-ordinate activities. After six months the ICL will cease active engagement. To assess maintenance of activities, interviews with relevant stakeholders will be conducted after the ICL withdraws at months 7, 11 and 15.

The ICL will keep a reflective diary to document observations of practice, liaison with staff, family and residents, examples of improvements in care and personal responses to the role. The diary will influence implementation by enabling the ICL to reflect on her role in situ and modify her approach if required. The ICL will keep a daily log of time spent on tasks related to implementation to enable estimation of costs. It was expected that care home and external healthcare professional time to be involved in Intervention meetings and training will be consistent with their usual job descriptions and so will not be considered an additional cost of the Intervention and any opportunity costs will be offset by the training skills acquired. During the six months at the care homes, the ICL will collect monthly care home-wide data on the number of residents with: documented resuscitation status; a pain management plan; preferred place of death recorded; and hospital admissions. Data on emergency phone calls and location of deaths will be collected. Resident assessments undertaken by the ICL will not be used as research data. These data will be maintained within the care home as clinical information according to their governance polices. Findings from assessments, however, can be reflected on in the anonymised ICL diary and used to inform other Intervention activities such as training. Formal training sessions will be evaluated using evaluation forms.

Monthly individual resident outcome data will be collected by researchers (not the ICL) from residents assessed by the ICL and their family carers. As residents are unlikely to have capacity to make an informed decision to participate in research, care home managers will invite next of kin/primary contact to give consent for this monthly outcome data to be collected. If a next of kin is not available, a professional consultee will provide agreement according to UK's Mental Capacity Act (2005). Residents will be recruited during the first four months of implementation to ensure collection of at least three months of outcome data.

Process data will reported as total number of activities undertaken and total ICL hours spent on different activities. ICL hours spent on activities associated with the implementation will be costed using the UK Department of Health and Health Education England tariffs to estimate the cost of engaging the ICL. Training evaluations and outcomes (facility wide and individual) will be analysed using descriptive statistics using statistical package IBM SPSS Version 22 (2013). Outcome data will be used for monitoring potential harm and to examine the feasibility of collecting measures in future trials, hence a sample size calculation will not performed. Using descriptive statistics we will compare individual outcomes with data from our earlier cohort study but the sample size will be too small for statistical analyses.

Semi-structured interviews will be conducted with a purposive sample of care home staff and external healthcare professionals after the ICL has completed six months at each site and also to assess sustainability after the ICL has left. Interviews will be conducted at months 7, 11 and 15. Family carers who agree for a resident to have monthly individual data collection will be invited to take part in an interview at month 7. Participants will provide written informed consent prior to each interview. Interviews will be audio-recorded and transcribed verbatim. The interviews aim to: assess participants' views of the strengths and weaknesses of the Intervention; identify whether any changes in practice to improve the care of residents with advanced dementia and their family carers were implemented due to the Intervention; and explore whether these changes were maintained after the ICL left. Transcripts will be checked against the audio-recording. One researcher involved in interviewing and transcribing will code all transcripts using QSR International Pty Ltd NVivo V10 software (2012). Framework analysis will be used (Gale, 2013), based on Grol's (2007) phases of implementation. Small chunks of text will be extracted and coded, summarising their content. Coded text will be grouped into larger themes within each of the five phases. Themes will be reviewed and checked by a second researcher.

Conditions
Dementia
Being tested
Compassion Intervention
Keywords
Terminal care, Residential facilities, Integrated health care systems, Interdisciplinary health team, Palliative care
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Compassion InterventionOther

    See arm description

Study groups in NCT02840318
Study groupRoleWhat they receive
Compassion InterventionExperimentalCoordinated by the ICL who co-ordinates key activities at each site to address the two core components of the Intervention. Component 1 activities include: (a) person-centred assessment of residents, focussing on their physical, psychological, emotional and social needs, (b) meetings of the core care team (General practitioner, care home nurse and/or manager and ICL) and (c) meetings of the wider multidisciplinary care teams (including care home staff, ICL, and external healthcare professionals such as geriatrician, palliative care, mental health etc). Activities to facilitate component 2 include: (d) staff training sessions, education and support for staff and family carers. Training sessions are run by the ICL and logistics of training is planned at core meetings.
Receives: Other: Compassion Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Assessment in Advanced Dementia

    Warden, 2003

    Measured: up to 6 months

Secondary outcomes (5)
  1. Waterlow Scale

    pressure ulcer risk (Waterlow, 1985)

    Measured: up to 6 months

  2. Neuropsychiatric Inventory

    (Cummings, 1994)

    Measured: up to 6 months

  3. Cohen Mansfield Agitation Inventory

    (Cohen Mansfield, 1989)

    Measured: Monthly up to 6 months

  4. Symptom Management at End of Life in Dementia

    (Kiely, 2006)

    Measured: up to 6 months

  5. Quality of Life in Late Stage Dementia Scale

    (Weiner, 2000)

    Measured: up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2016 (estimated)
  2. Study startFeb 2014
  3. Primary completionDec 2014
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02840318
Sponsor's protocol ID
14/007
Status last verified
Feb 2014
First submitted
19 Jul 2016
Last updated
16 Aug 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Chambers DA, Glasgow RE, Stange KC. The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implement Sci. 2013 Oct 2;8:117. doi: 10.1186/1748-5908-8-117.

    PubMed 24088228
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.

    PubMed 3558716
  • Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989 May;44(3):M77-84. doi: 10.1093/geronj/44.3.m77.

    PubMed 2715584
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 Dec;44(12):2308-14. doi: 10.1212/wnl.44.12.2308.

    PubMed 7991117
  • Elliott M, Harrington J, Moore K, Davis S, Kupeli N, Vickerstaff V, Gola A, Candy B, Sampson EL, Jones L. A protocol for an exploratory phase I mixed-methods study of enhanced integrated care for care home residents with advanced dementia: the Compassion Intervention. BMJ Open. 2014 Jun 17;4(6):e005661. doi: 10.1136/bmjopen-2014-005661.

    PubMed 24939815
  • Fitch K, Bernstein S, Aguilar M, Burnand B, LaCalle J, Lázaro P, et al. The RAND/UCLA Appropriateness Method User's Manual Santa Monica: RAND, 2001.

  • Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013 Sep 18;13:117. doi: 10.1186/1471-2288-13-117.

    PubMed 24047204
  • Grol RP, Bosch MC, Hulscher ME, Eccles MP, Wensing M. Planning and studying improvement in patient care: the use of theoretical perspectives. Milbank Q. 2007;85(1):93-138. doi: 10.1111/j.1468-0009.2007.00478.x.

    PubMed 17319808
  • Jones L, Candy B, Davis S, Elliott M, Gola A, Harrington J, Kupeli N, Lord K, Moore K, Scott S, Vickerstaff V, Omar RZ, King M, Leavey G, Nazareth I, Sampson EL. Development of a model for integrated care at the end of life in advanced dementia: A whole systems UK-wide approach. Palliat Med. 2016 Mar;30(3):279-95. doi: 10.1177/0269216315605447. Epub 2015 Sep 9.

    PubMed 26354388
  • Jones L, Harrington J, Scott S, Davis S, Lord K, Vickerstaff V, Round J, Candy B, Sampson EL. CoMPASs: IOn programme (Care Of Memory Problems in Advanced Stages of dementia: Improving Our Knowledge): protocol for a mixed methods study. BMJ Open. 2012 Nov 27;2(6):e002265. doi: 10.1136/bmjopen-2012-002265. Print 2012.

    PubMed 23187973
  • Kiely DK, Volicer L, Teno J, Jones RN, Prigerson HG, Mitchell SL. The validity and reliability of scales for the evaluation of end-of-life care in advanced dementia. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):176-81. doi: 10.1097/00002093-200607000-00009.

    PubMed 16917188
  • Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653-9. No abstract available.

    PubMed 3249767
  • Volicer L, Hurley AC, Lathi DC, Kowall NW. Measurement of severity in advanced Alzheimer's disease. J Gerontol. 1994 Sep;49(5):M223-6. doi: 10.1093/geronj/49.5.m223.

    PubMed 8056941
  • Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc. 2003 Jan-Feb;4(1):9-15. doi: 10.1097/01.JAM.0000043422.31640.F7.

    PubMed 12807591
  • Waterlow J. Pressure sores: a risk assessment card. Nurs Times. 1985 Nov 27-Dec 3;81(48):49-55. No abstract available.

    PubMed 3853163

Questions about this trial

What is this clinical trial studying?

A study testing Compassion Intervention in people with Dementia, run by University College, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Assessment in Advanced Dementia (time frame: up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02840318, which also lists 20 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02840318 | AzTrials